RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: transitional cell carcinoma
Accession: DOID:2671
browse the term
Definition: A carcinoma that derives_from transitional epithelial cells. (DO)
Synonyms: exact_synonym: TCC; transitional carcinoma; transitional cell carcinomas; transitional cell tumor; urothelial carcinoma; urothelial cell carcinoma
narrow_synonym: invasive transitional cell carcinoma; transitional cell carcinoma of the bladder
related_synonym: transitional cell neoplasm
primary_id: MESH:D002295
alt_id: OMIA:001512
xref: EFO:0008528 ; EFO:1000601 ; GARD:7794 ; NCI:C128126 ; NCI:C2930 ; NCI:C6783
For additional species annotation, visit the
Alliance of Genome Resources .
G
Akt1
AKT serine/threonine kinase 1
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 PMID:19418217 PMID:19487299 PMID:19853286 PMID:20233444 PMID:20453058 PMID:21464312 PMID:21512767 PMID:21793738 PMID:22538770 PMID:22610119 PMID:22722201 PMID:22722839 PMID:22980975 PMID:23237847 PMID:23348505 PMID:23700467 PMID:23728071 PMID:23934607 PMID:24190505 PMID:24657128 PMID:25157968 PMID:26619011 PMID:28492532 More...
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Ambp
alpha-1-microglobulin/bikunin precursor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:14644129
NCBI chr 5:76,568,094...76,578,416
Ensembl chr 5:76,568,094...76,578,331
G
Angpt1
angiopoietin 1
disease_progression
ISO
RGD
PMID:15517881
RGD:2293863
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
G
Angpt2
angiopoietin 2
disease_progression
ISO
RGD
PMID:15705099
RGD:2293853
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:71,088,364...71,138,804
G
Anxa1
annexin A1
severity
IEP
mRNA, protein:increased expression:urinary bladder
RGD
PMID:17994624
RGD:2306889
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Apaf1
apoptotic peptidase activating factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17133271
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Apc
APC regulator of WNT signaling pathway
ISO
DNA:methylation: :
RGD
PMID:21599969
RGD:7242057
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
G
Apoa1
apolipoprotein A1
severity
IEP ISO
mRNA:decreased expression:urinary bladder protein:increased expression:urine
RGD
PMID:19399409 PMID:21496341
RGD:2325183 , RGD:7241214
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Areg
amphiregulin
ISO
mRNA:increased expression:urinary bladder
RGD
PMID:16469638
RGD:2289980
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Arid1a
AT-rich interaction domain 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21822268
NCBI chr 5:145,908,181...145,981,609
Ensembl chr 5:145,908,181...145,985,564
G
Bcl2
BCL2, apoptosis regulator
ISO
RGD
PMID:18047955
RGD:1643477
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
ISO
RGD
PMID:18047955
RGD:1643477
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Birc5
baculoviral IAP repeat-containing 5
disease_progression
ISO
mRNA:increased expression:urine protein:increased expression:urinary bladder
RGD
PMID:17559031 PMID:17828507 PMID:18172282
RGD:2298937 , RGD:2293099 , RGD:2293093
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:12068308 PMID:12460918 PMID:12460919 PMID:12960123 PMID:14612909 PMID:14679157 PMID:14688025 PMID:15035987 PMID:16439621 PMID:16474404 PMID:16825433 PMID:17096326 PMID:17119447 PMID:17311103 PMID:17603483 PMID:18039235 PMID:18042262 PMID:18186519 PMID:18368129 PMID:18413255 PMID:18794803 PMID:19010912 PMID:19206169 PMID:19238210 PMID:19376813 PMID:19383316 PMID:19537845 PMID:19913317 PMID:20350999 PMID:20619739 PMID:21129611 PMID:21483012 PMID:21784453 PMID:22180495 PMID:22310681 PMID:22649091 PMID:22773810 PMID:23273605 PMID:23352452 PMID:23833300 PMID:24033266 PMID:24303953 PMID:24446311 PMID:24920063 PMID:25157968 PMID:25463315 PMID:25741868 PMID:26619011 PMID:27236105 PMID:27276561 PMID:28492532 PMID:29595366 PMID:29907801 More...
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
G
Brd4
bromodomain containing 4
disease_progression
ISO
mRNA,protein:increased expression:bladder:
RGD
PMID:25120803
RGD:9586352
NCBI chr 7:11,216,446...11,296,029
Ensembl chr 7:11,216,446...11,295,539
G
Bsg
basigin (Ok blood group)
disease_progression
ISO
RGD
PMID:17671123
RGD:2289051
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
G
Car9
carbonic anhydrase 9
disease_progression
ISO
RGD
PMID:15069539
RGD:2298947
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
G
Casp3
caspase 3
ISO
RGD
PMID:18172282
RGD:2293093
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cav1
caveolin 1
disease_progression
ISO
protein:increased expression:urinary bladder
RGD
PMID:16328005
RGD:2289103
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Cbx7
chromobox 7
severity
ISO
mRNA:decreased expression:urinary bladder:
RGD
PMID:18984978
RGD:9587361
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
G
Ccnd1
cyclin D1
IEP ISO
mRNA, protein:increased expression:urinary bladder CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12151359 PMID:16896691
RGD:2289144
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd2
cyclin D2
IDA
DNA:hypermethylation:urinary bladder, urine
RGD
PMID:17017434
RGD:2289150
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
G
Cd44
CD44 molecule (Indian blood group)
ISO
mRNA:splice variants:kidney pelvis, ureter
RGD
PMID:10022688
RGD:2289363
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd82
Cd82 molecule
ISO
RGD
PMID:17393117
RGD:2289390
NCBI chr 3:79,387,361...79,431,847
Ensembl chr 3:79,385,887...79,431,809
G
Cd9
CD9 molecule
disease_progression
ISO
protein:decreased expression:urinary bladder
RGD
PMID:17393117
RGD:2289390
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
G
Cdk1
cyclin-dependent kinase 1
severity
ISO
RGD
PMID:18245534
RGD:2701900
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk4
cyclin-dependent kinase 4
disease_progression
ISO
RGD
PMID:15161057
RGD:2293580
NCBI chr 7:62,885,647...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12151359 PMID:18640142
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
disease_progression
ISO
RGD
PMID:10886076
RGD:2293608
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
disease_progression
ISO
DNA:hypermethylation:promoter ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar RGD
PMID:7780957 PMID:8521414 PMID:9324288 PMID:10491434 PMID:16234564 PMID:16896043 PMID:21462282 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28492532 PMID:16316628 More...
RGD:2289686
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cdkn2a_v1
cyclin-dependent kinase inhibitor 2A, variant 1
disease_progression
ISO
DNA:hypermethylation:promoter
RGD
PMID:16316628
RGD:2289686
G
Cdkn2a_v2
cyclin-dependent kinase inhibitor 2A, variant 2
disease_progression
ISO
DNA:hypermethylation:promoter
RGD
PMID:16316628
RGD:2289686
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
ISO
mRNA:decreased expression:urinary bladder
RGD
PMID:11720438
RGD:2289697
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
G
Chd6
chromodomain helicase DNA binding protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21822268
NCBI chr 3:149,596,509...149,757,765
Ensembl chr 3:149,596,509...149,757,755
G
Cnot9
CCR4-NOT transcription complex subunit 9
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:26619011
NCBI chr 9:76,084,269...76,109,111
Ensembl chr 9:76,084,334...76,109,100
G
Crebbp
CREB binding protein
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
CTD ClinVar
PMID:21390126 PMID:21680795 PMID:21796119 PMID:21822268 PMID:22832583 PMID:23334668 PMID:23685749 PMID:23778141 PMID:26087898 PMID:26619011 PMID:27257180 PMID:28492532 PMID:28970362 PMID:29551561 PMID:33560380 More...
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
G
Csf3
colony stimulating factor 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7525883 PMID:7543010
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Ctnna1
catenin alpha 1
ISO
RGD
PMID:16426728
RGD:2298486
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
G
Ctnnb1
catenin beta 1
disease_progression
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar RGD
PMID:9065402 PMID:9065403 PMID:9294210 PMID:9927029 PMID:10027390 PMID:10192393 PMID:10391090 PMID:10435629 PMID:10666372 PMID:11351304 PMID:11930117 PMID:11950921 PMID:12124804 PMID:15133491 PMID:19234609 PMID:24788118 PMID:25157968 PMID:25741868 PMID:26619011 PMID:26822237 PMID:16426728 PMID:17363521 More...
RGD:2298486 , RGD:2289818
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Ctsb
cathepsin B
ISO
protein:increased expression:urinary bladder
RGD
PMID:15183956
RGD:2315615
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Ctsh
cathepsin H
ISO
protein:increased expression:urinary bladder
RGD
PMID:15183956
RGD:2315615
NCBI chr 8:90,608,941...90,627,824
Ensembl chr 8:90,608,941...90,627,824
G
Dapk1
death associated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17133271
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
G
Daxx
death-domain associated protein
ISO
RGD
PMID:23819605
RGD:9587843
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
G
Egfr
epidermal growth factor receptor
ISO
mRNA:decreased expression:urinary bladder
RGD
PMID:16469638 PMID:3499520
RGD:2289980 , RGD:10395259
NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Ep300
E1A binding protein p300
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
CTD ClinVar
PMID:21822268 PMID:26619011
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Erbb2
erb-b2 receptor tyrosine kinase 2
severity
ISO
mRNA:increased expression:urinary bladder protein:increased expression:urinary bladder ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar RGD
PMID:16397024 PMID:18413839 PMID:22046346 PMID:22908275 PMID:23220880 PMID:25157968 PMID:26619011 PMID:14614020 PMID:17987577 More...
RGD:2298506 , RGD:2289927
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Erbb3
erb-b2 receptor tyrosine kinase 3
ISO
mRNA:increased expression:urinary bladder ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar RGD
PMID:26619011 PMID:16469638 PMID:14614020
RGD:2289980 , RGD:2298506
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
G
Erbb4
erb-b2 receptor tyrosine kinase 4
ISO
mRNA:increased expression:urinary bladder mRNA:decreased expression:urinary bladder
RGD
PMID:14614020 PMID:16469638
RGD:2298506 , RGD:2289980
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
G
Espl1
extra spindle pole bodies like 1, separase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24121792
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
G
Esr2
estrogen receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16700038
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Fas
Fas cell surface death receptor
disease_progression
ISO
protein:increased expression:urine protein:decreased expression
RGD
PMID:16541433 PMID:12470426 PMID:16091761
RGD:2290058 , RGD:2290077 , RGD:2290075
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
disease_progression
ISO
RGD
PMID:12470426 PMID:12651606
RGD:2290077 , RGD:2290076
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fbxw7
F-box and WD repeat domain containing 7
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:25741868 PMID:26619011
NCBI chr 2:170,150,552...170,310,698
Ensembl chr 2:170,149,694...170,309,941
G
Fgf1
fibroblast growth factor 1
disease_progression
ISO
protein:increased expression:urine, urinary bladder
RGD
PMID:7690426
RGD:2298518
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
G
Fgf2
fibroblast growth factor 2
ISO
protein:decreased expression:urinary bladder
RGD
PMID:7549793
RGD:2298517
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Fgfr1
Fibroblast growth factor receptor 1
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:25705862 PMID:26619011 PMID:26942290 PMID:33448156
NCBI chr16:66,492,445...66,546,731
Ensembl chr16:66,494,042...66,547,350
G
Fgfr2
fibroblast growth factor receptor 2
ISO
mRNA, protein:decreased expression:urinary bladder
RGD
PMID:9018118
RGD:2301194
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
G
Fgfr3
fibroblast growth factor receptor 3
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder CTD Direct Evidence: marker/mechanism
ClinVar CTD RGD
PMID:1908846 PMID:7773297 PMID:8589699 PMID:8845844 PMID:8858131 PMID:9438390 PMID:9677066 PMID:9843049 PMID:10073901 PMID:10471491 PMID:10696568 PMID:11241532 PMID:11429702 PMID:11529856 PMID:12833394 PMID:15772091 PMID:16841094 PMID:18642369 PMID:19088846 PMID:19331127 PMID:19381019 PMID:20301540 PMID:20542753 PMID:21273588 PMID:22869148 PMID:23200862 PMID:24121792 PMID:24419316 PMID:24476948 PMID:25157968 PMID:25606676 PMID:25614871 PMID:25741868 PMID:26619011 PMID:28249712 PMID:28492532 PMID:11314002 More...
RGD:2289866
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
G
Ggh
gamma-glutamyl hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19815704
NCBI chr 5:33,529,880...33,552,790
Ensembl chr 5:33,529,880...33,552,787
G
Gpx1
glutathione peroxidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15247771
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gstm1
glutathione S-transferase mu 1
onset
ISO
protein:increased expression:urinary bladder mucosa
RGD
PMID:9111645 PMID:18199464
RGD:2293800 , RGD:2293824
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstt1
glutathione S-transferase theta 1
ISO
protein:increased expression:urinary bladder mucosa
RGD
PMID:9111645
RGD:2293800
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
H19
H19 imprinted maternally expressed transcript
IEP
mRNA:increased expression:urinary bladder
RGD
PMID:15378645
RGD:2306177
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
G
Hras
HRas proto-oncogene, GTPase
ISO
DNA, mRNA:mutation, increased expression:urinary bladder CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
CTD ClinVar RGD
PMID:1904555 PMID:3433577 PMID:3510078 PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17979197 PMID:18039947 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20660566 PMID:20859122 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25695684 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28139825 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32371413 PMID:33372952 PMID:34008892 PMID:168335863 PMID:19303097 More...
RGD:2314836
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Hrh2
histamine receptor H 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:6224980
NCBI chr17:10,368,355...10,407,791
Ensembl chr17:10,368,298...10,407,631
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 PMID:21352804 PMID:21446021 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22898539 PMID:23558169 PMID:24606448 PMID:25043048 PMID:25157968 PMID:25741868 PMID:26619011 PMID:27993330 PMID:30231226 PMID:36201590 More...
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
G
Ifnb1
interferon beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2297754
NCBI chr 5:103,020,969...103,021,523
Ensembl chr 5:103,020,969...103,021,523
G
Igfbp3
insulin-like growth factor binding protein 3
disease_progression
ISO
DNA:hypermethylation CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21347663 PMID:17541304
RGD:2301466
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Kdm6a
lysine demethylase 6A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21822268
NCBI chr X:4,337,466...4,477,100
Ensembl chr X:4,337,750...4,477,062
G
Kdr
kinase insert domain receptor
disease_progression
ISO
RGD
PMID:16515971 PMID:18645275
RGD:2291934 , RGD:2301755
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kiss1
KiSS-1 metastasis-suppressor
ISO
RGD
PMID:17164231
RGD:2292127
NCBI chr13:44,774,823...44,780,707
Ensembl chr13:44,774,823...44,780,612
G
Kiss1r
KISS1 receptor
severity
ISO
RGD
PMID:17164231
RGD:2292127
NCBI chr 7:9,785,135...9,790,283
Ensembl chr 7:9,785,135...9,788,793
G
Kmt2a
lysine methyltransferase 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21822268
NCBI chr 8:45,116,771...45,193,320
Ensembl chr 8:45,118,814...45,193,181
G
Kmt2c
lysine methyltransferase 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21822268
NCBI chr 4:9,620,638...9,834,787
Ensembl chr 4:9,609,627...9,833,539
G
Kras
KRAS proto-oncogene, GTPase
ISO
mRNA:increased expression:urinary bladder ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar RGD
PMID:2278970 PMID:3122217 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16434492 PMID:16618717 PMID:18316791 PMID:18794081 PMID:19075190 PMID:19114683 PMID:19679400 PMID:20921462 PMID:20921465 PMID:21228335 PMID:22407852 PMID:22722830 PMID:23325582 PMID:25157968 PMID:26619011 PMID:19303097 More...
RGD:2314836
NCBI chr 4:178,185,418...178,218,484
G
Lrrc56
leucine rich repeat containing 56
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:1904555 PMID:3510078 PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17979197 PMID:18039947 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20660566 PMID:20859122 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25695684 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28139825 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32371413 PMID:33372952 PMID:34008892 PMID:168335863 More...
NCBI chr 1:196,299,843...196,315,170
Ensembl chr 1:196,299,846...196,315,172
G
Map2k1
mitogen activated protein kinase kinase 1
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:17366577 PMID:17551924 PMID:19915144 PMID:21107320 PMID:22197931 PMID:22588879 PMID:23569304 PMID:24033266 PMID:24803665 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28049852 More...
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
G
Mapk1
mitogen activated protein kinase 1
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:26619011
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mir100
microRNA 100
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026881
NCBI chr 8:41,901,225...41,901,304
Ensembl chr 8:41,901,225...41,901,304
G
Mir145
microRNA 145
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026881
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
G
Mir205
microRNA 205
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25586904
NCBI chr13:105,035,878...105,035,985
Ensembl chr13:105,035,878...105,035,985
G
Mir34b
microRNA 34b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026881
NCBI chr 8:51,410,244...51,410,327
Ensembl chr 8:51,410,244...51,410,327
G
Mir532
microRNA 532
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30639441
NCBI chr X:15,247,315...15,247,393
Ensembl chr X:15,247,315...15,247,393
G
Mir99a
microRNA 99a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30026881
NCBI chr11:16,200,443...16,200,523
Ensembl chr11:16,200,443...16,200,523
G
Mmp14
matrix metallopeptidase 14
ISO
RGD
PMID:9751409
RGD:2314950
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
G
Mmp15
matrix metallopeptidase 15
ISO
RGD
PMID:9751409
RGD:2314950
NCBI chr19:9,663,449...9,684,943
Ensembl chr19:9,663,449...9,684,943
G
Mmp2
matrix metallopeptidase 2
ISO
protein:increased expression:plasma
RGD
PMID:16901349
RGD:2290349
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Msh2
mutS homolog 2
ISO
associated with Lynch syndrome
RGD
PMID:22883484
RGD:126790557
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
G
Mthfr
methylenetetrahydrofolate reductase
susceptibility
ISO
DNA:transversion:cds:g.1298A>C (human)
RGD
PMID:21046286
RGD:6893477
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Mtor
mechanistic target of rapamycin kinase
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:24625776
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Nat2
N-acetyltransferase 2
susceptibility
ISO
DNA:polymorphism
RGD
PMID:12402313
RGD:2303765
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Ncor1
nuclear receptor co-repressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21822268
NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:26619011 PMID:29018201
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
G
Nras
NRAS proto-oncogene, GTPase
ISO
mRNA:increased expression:urinary bladder ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar RGD
PMID:1654209 PMID:2278970 PMID:2407301 PMID:2674680 PMID:2989702 PMID:3102434 PMID:3122217 PMID:6587382 PMID:8120410 PMID:10821536 PMID:12460918 PMID:12727991 PMID:14508525 PMID:15899789 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17332249 PMID:17517660 PMID:17699718 PMID:18375819 PMID:18390968 PMID:18633438 PMID:18668139 PMID:18948947 PMID:19075190 PMID:19657110 PMID:19775298 PMID:19880792 PMID:19966803 PMID:20130576 PMID:20149136 PMID:20179705 PMID:20406486 PMID:20619739 PMID:20736745 PMID:21079152 PMID:21107323 PMID:21305640 PMID:21576590 PMID:21729679 PMID:21829508 PMID:22407852 PMID:22499344 PMID:22718121 PMID:22761467 PMID:22773810 PMID:22962325 PMID:23076151 PMID:23392294 PMID:23400451 PMID:23414587 PMID:23431193 PMID:23515407 PMID:23538902 PMID:23569304 PMID:23614898 PMID:24006476 PMID:24033266 PMID:24148783 PMID:24370118 PMID:24671188 PMID:25157968 PMID:25348872 PMID:25695684 PMID:25741868 PMID:26619011 PMID:26821351 PMID:27050078 PMID:27993330 PMID:28492532 PMID:28780248 PMID:19303097 More...
RGD:2314836
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
G
Ogg1
8-oxoguanine DNA glycosylase
severity
ISO
DNA:missense mutation:exon:p.S326C (rs1052133) (human)
RGD
PMID:22110223
RGD:8657372
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Pabpc1
poly(A) binding protein, cytoplasmic 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25783786
NCBI chr 7:67,777,438...67,789,731
Ensembl chr 7:67,777,381...67,789,744
G
Pak1
p21 (RAC1) activated kinase 1
severity
ISO
protein:increased expression:urinary bladder
RGD
PMID:18167251
RGD:2299157
NCBI chr 1:152,111,172...152,226,390
Ensembl chr 1:152,111,188...152,226,383
G
Phb1
prohibitin 1
disease_progression
ISO
protein:increased expression:urinary bladder
RGD
PMID:17465217
RGD:2292396
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 PMID:15805248 PMID:15930273 PMID:16353168 PMID:16906227 PMID:16930767 PMID:17673550 PMID:18371219 PMID:18676830 PMID:18725974 PMID:19029981 PMID:19223544 PMID:19366826 PMID:19513541 PMID:19671852 PMID:19903786 PMID:20177704 PMID:20453058 PMID:20619739 PMID:21078999 PMID:21430269 PMID:21558396 PMID:21824802 PMID:22162582 PMID:22162589 PMID:22209294 PMID:22271473 PMID:22357840 PMID:22370636 PMID:22658544 PMID:22729222 PMID:22729223 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23408298 PMID:23888070 PMID:23946963 PMID:24033266 PMID:24265155 PMID:24497998 PMID:24559322 PMID:24782230 PMID:25157968 PMID:25599672 PMID:25741868 PMID:25880439 PMID:26266975 PMID:26266985 PMID:26351730 PMID:26619011 PMID:26627007 PMID:26637981 PMID:26822237 PMID:26851524 PMID:27626068 PMID:27631024 PMID:28151489 PMID:28425981 PMID:28492532 PMID:28941273 PMID:29661094 PMID:29988677 PMID:30063105 PMID:30376034 PMID:30543347 PMID:31536475 PMID:31775759 PMID:32778138 PMID:34008892 PMID:34496175 More...
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
G
Pla2g4a
phospholipase A2 group IVA
IEP
mRNA:increased expression:bladder
RGD
PMID:16621493
RGD:1642457
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
G
Plau
plasminogen activator, urokinase
severity
ISO
protein:increased expression:urinary tract, tumor (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14644129 PMID:15191676
RGD:7241280
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Pou5f1
POU class 5 homeobox 1
ISO
mRNA, protein:increased expression:urinary bladder
RGD
PMID:17205510
RGD:2292435
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
G
Prom1
prominin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32673656
NCBI chr14:66,989,545...67,094,534
Ensembl chr14:66,990,160...67,094,527
G
Pten
phosphatase and tensin homolog
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:26619011 PMID:27535533 PMID:28492532 PMID:29706350
NCBI chr 1:230,631,303...230,696,754
Ensembl chr 1:230,630,338...230,696,838
G
Ptges
prostaglandin E synthase
ISO IEP
protein:increased expression:urinary bladder mRNA:increased expression:urinary bladder
RGD
PMID:14499677 PMID:16621493
RGD:2300088 , RGD:1642457
NCBI chr 3:14,177,892...14,189,236
G
Ptgs2
prostaglandin-endoperoxide synthase 2
disease_progression
ISO
protein:increased expression:urinary bladder CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10582676 PMID:10873095 PMID:12151359 PMID:12664575 PMID:18449376
RGD:2300124
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
G
Rad50
RAD50 double strand break repair protein
ISO
RGD
PMID:16288216
RGD:2293511
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
G
Rassf1
Ras association domain family member 1
ISO
DNA, protein:hypermethylation, decreased expression:promoter, urinary bladder
RGD
PMID:18480993
RGD:2299862
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
G
Rel
REL proto-oncogene, NF-kB subunit
ISO
RGD
PMID:12452071
RGD:2300270
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
G
Relb
RELB proto-oncogene, NF-kB subunit
ISO
mRNA, protein:increased expression:urinary bladder mucosa, nucleus
RGD
PMID:12452071
RGD:2300270
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Rheb
Ras homolog, mTORC1 binding
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:26619011
NCBI chr 4:10,278,970...10,320,160
Ensembl chr 4:10,279,370...10,320,160
G
Rxra
retinoid X receptor alpha
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:26619011
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Sf3b1
splicing factor 3b, subunit 1
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:25741868 PMID:26619011
NCBI chr 9:56,492,403...56,532,300
Ensembl chr 9:56,492,403...56,532,300
G
Sfn
stratifin
disease_progression
ISO
DNA:hypermethylation:promoter
RGD
PMID:16964403
RGD:2299929
Ensembl chr 5:145,826,201...145,831,314
G
Skp2
S-phase kinase associated protein 2
disease_progression
ISO
protein:increased expression:kidney
RGD
PMID:15351619
RGD:2315044
NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338
G
Slc3a2
solute carrier family 3 member 2
IEP
protein:increased expression:bladder
RGD
PMID:28339760
RGD:151361118
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
G
Slc7a5
solute carrier family 7 member 5
IEP
protein:increased expression:bladder
RGD
PMID:28339760
RGD:151361118
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Smad4
SMAD family member 4
ISO
protein:decreased expression:urinary bladder
RGD
PMID:16859125
RGD:2299980
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
G
Sox2
SRY-box transcription factor 2
disease_progression
ISO
RGD
PMID:22899292
RGD:8661672
NCBI chr 2:117,536,929...117,539,338
Ensembl chr 2:117,536,929...117,539,338
G
Spink1
serine peptidase inhibitor, Kazal type 1
disease_progression
ISO
protein:increased expression:urine
RGD
PMID:15963628
RGD:2300385
NCBI chr18:35,870,723...35,882,693
Ensembl chr18:35,824,550...35,882,642
G
Stag2
stromal antigen 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24121792
NCBI chr X:120,974,687...121,105,677
Ensembl chr X:120,974,857...121,105,677
G
Tacc3
transforming, acidic coiled-coil containing protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24121792
NCBI chr14:77,051,209...77,065,343
Ensembl chr14:77,051,215...77,065,219
G
Terc
telomerase RNA component
disease_progression
ISO
RNA:increased expression:ureter urothelium
RGD
PMID:10570439
RGD:2291974
NCBI chr 2:112,815,654...112,816,041
G
Tert
telomerase reverse transcriptase
disease_progression
ISO
mRNA:increased expression:urine, urothelial cell
RGD
PMID:17961306
RGD:2291982
NCBI chr 1:29,637,213...29,659,509
Ensembl chr 1:29,637,506...29,659,561
G
Tff1
trefoil factor 1
ISO
protein:increased expression:urinary bladder urothelium
RGD
PMID:7965392
RGD:2298573
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Tfrc
transferrin receptor
disease_progression
ISO
RGD
PMID:9373912
RGD:2292023
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Timp1
TIMP metallopeptidase inhibitor 1
ISO
protein:decreased expression:plasma
RGD
PMID:16901349
RGD:2290349
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Timp2
TIMP metallopeptidase inhibitor 2
ISO
protein:decreased expression:plasma
RGD
PMID:16901349
RGD:2290349
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:3361654
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
ISO
protein:increased expression:bladder CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
CTD ClinVar RGD
PMID:1349175 PMID:1359493 PMID:1565143 PMID:1565144 PMID:1569604 PMID:1591732 PMID:1631137 PMID:1631151 PMID:1644930 PMID:1673792 PMID:1679237 PMID:1683921 PMID:1686725 PMID:1737852 PMID:1978757 PMID:2046748 PMID:2259385 PMID:4122735 PMID:7565304 PMID:7707106 PMID:7732013 PMID:7783166 PMID:7791795 PMID:7881428 PMID:7887414 PMID:8023157 PMID:8062826 PMID:8080050 PMID:8099841 PMID:8118819 PMID:8164043 PMID:8242631 PMID:8344492 PMID:8364550 PMID:8401536 PMID:8423216 PMID:8425176 PMID:8464896 PMID:8479749 PMID:8527048 PMID:8550239 PMID:8633021 PMID:8718514 PMID:8825920 PMID:8829627 PMID:8869100 PMID:9020384 PMID:9096669 PMID:9157982 PMID:9218725 PMID:9242456 PMID:9268986 PMID:9290701 PMID:9364015 PMID:9546439 PMID:9569050 PMID:9572492 PMID:9598730 PMID:9627118 PMID:9632751 PMID:9635828 PMID:9662334 PMID:9667734 PMID:9825943 PMID:10229196 PMID:10411893 PMID:10432928 PMID:10519380 PMID:10567903 PMID:10589545 PMID:10713666 PMID:10761705 PMID:10797439 PMID:10864200 PMID:10871862 PMID:10914716 PMID:10922393 PMID:11051239 PMID:11051241 PMID:11139324 PMID:11180592 PMID:11370630 PMID:11429705 PMID:11479205 PMID:11593407 PMID:11782540 PMID:11793474 PMID:11896595 PMID:11900253 PMID:11920788 PMID:11920959 PMID:12076704 PMID:12124823 PMID:12406399 PMID:12506399 PMID:12509279 PMID:12672316 PMID:12726864 PMID:12826609 PMID:12885464 PMID:12909720 PMID:12917626 PMID:14559903 PMID:14673037 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15381368 PMID:15390294 PMID:15541116 PMID:15580553 PMID:15607980 PMID:15611505 PMID:15722483 PMID:15781620 PMID:15825182 PMID:15850016 PMID:15925506 PMID:15951970 PMID:15977174 PMID:15982667 PMID:16288208 PMID:16312222 PMID:16322298 PMID:16401470 PMID:16489069 PMID:16494995 PMID:16508005 PMID:16551709 PMID:16682957 PMID:16736287 PMID:16818505 PMID:16827139 PMID:16861262 PMID:17015838 PMID:17308077 PMID:17311302 PMID:17390010 PMID:17417627 PMID:17427234 PMID:17540308 PMID:17541742 PMID:17567834 PMID:17572079 PMID:17606709 PMID:17636407 PMID:17724467 PMID:18208484 PMID:18307025 PMID:18453682 PMID:18511570 PMID:18555592 PMID:18689542 PMID:18989156 PMID:19012332 PMID:19101993 PMID:19147582 PMID:19171880 PMID:19336573 PMID:19367569 PMID:19378321 PMID:19468865 PMID:19556618 PMID:19681600 PMID:19834951 PMID:19913028 PMID:20013323 PMID:20113312 PMID:20127978 PMID:20128691 PMID:20308654 PMID:20407015 PMID:20505364 PMID:20506564 PMID:20516128 PMID:20522432 PMID:20589832 PMID:20693561 PMID:20805372 PMID:20972454 PMID:21056685 PMID:21059199 PMID:21159183 PMID:21187651 PMID:21232794 PMID:21305319 PMID:21319261 PMID:21343334 PMID:21356188 PMID:21483000 PMID:21484931 PMID:21519010 PMID:21535297 PMID:21552135 PMID:21601526 PMID:21626334 PMID:21674059 PMID:21761402 PMID:22006311 PMID:22052707 PMID:22090360 PMID:22110706 PMID:22186996 PMID:22198284 PMID:22233476 PMID:22265402 PMID:22484423 PMID:22672556 PMID:22710932 PMID:22713868 PMID:22768918 PMID:22811390 PMID:22887876 PMID:22899716 PMID:22915647 PMID:22919068 PMID:22923379 PMID:22929185 PMID:22983585 PMID:22999923 PMID:23031740 PMID:23161690 PMID:23165212 PMID:23172776 PMID:23175693 PMID:23246812 PMID:23259501 PMID:23263379 PMID:23265383 PMID:23334668 PMID:23538418 PMID:23625637 PMID:23630318 PMID:23667202 PMID:23792586 PMID:23894400 PMID:23950206 PMID:24033266 PMID:24038938 PMID:24122735 PMID:24381225 PMID:24384472 PMID:24487413 PMID:24501221 PMID:24573247 PMID:24603336 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24702488 PMID:24728327 PMID:24744791 PMID:24810334 PMID:24835218 PMID:25119136 PMID:25157968 PMID:25186627 PMID:25293557 PMID:25339994 PMID:25503501 PMID:25525159 PMID:25584008 PMID:25584637 PMID:25619955 PMID:25741868 PMID:25787918 PMID:25896519 PMID:25925845 PMID:25927356 PMID:25945745 PMID:25952993 PMID:25980754 PMID:26014290 PMID:26024390 PMID:26066407 PMID:26205489 PMID:26225655 PMID:26230955 PMID:26270727 PMID:26332594 PMID:26425688 PMID:26467025 PMID:26556299 PMID:26585234 PMID:26619011 PMID:26659639 PMID:26681312 PMID:26786923 PMID:26787237 PMID:26822237 PMID:26845104 PMID:26878390 PMID:26911350 PMID:26976419 PMID:27022024 PMID:27077130 PMID:27276561 PMID:27374712 PMID:27463065 PMID:27489289 PMID:27523101 PMID:27616075 PMID:27621308 PMID:27622479 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27873457 PMID:27895058 PMID:27959731 PMID:28135145 PMID:28152038 PMID:28160093 PMID:28279309 PMID:28356770 PMID:28369373 PMID:28453743 PMID:28472496 PMID:28492532 PMID:28724667 PMID:28802053 PMID:28861920 PMID:28873162 PMID:28975465 PMID:29025599 PMID:29070607 PMID:29126202 PMID:29324801 PMID:29470806 PMID:29478780 PMID:29489754 PMID:29581140 PMID:29752822 PMID:29753700 PMID:29979965 PMID:30076369 PMID:30128536 PMID:30216591 PMID:30224644 PMID:30299350 PMID:30311369 PMID:30318520 PMID:30322717 PMID:30327374 PMID:30352134 PMID:30450585 PMID:30630526 PMID:30675318 PMID:30720243 PMID:30816478 PMID:30840781 PMID:31016814 PMID:31105275 PMID:31121848 PMID:31206626 PMID:31300551 PMID:31494577 PMID:31748977 PMID:31775759 PMID:31882575 PMID:32000721 PMID:32295079 PMID:32401780 PMID:32475984 PMID:33208383 PMID:33245408 PMID:33257846 PMID:33300245 PMID:33372952 PMID:33471991 PMID:34026625 PMID:18270948 More...
RGD:2290532
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp63
tumor protein p63
ISO
RGD
PMID:18955789
RGD:2315431
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
G
Tp73
tumor protein p73
disease_progression
ISO
mRNA:increased expression:kidney
RGD
PMID:15492852
RGD:2290588
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
G
Tymp
thymidine phosphorylase
ISO
RGD
PMID:15841086
RGD:2293720
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
U2af1
U2 small nuclear RNA auxiliary factor 1
ISO
ClinVar Annotator: match by term: Transitional cell carcinoma of the bladder
ClinVar
PMID:22158538 PMID:23029227 PMID:23861105 PMID:24498085 PMID:26619011
NCBI chr20:9,742,904...9,753,840
Ensembl chr20:9,742,905...9,753,832
G
Vdr
vitamin D receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16080513
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Xpo5
exportin 5
severity
ISO
mRNA:increased expression:urothelium (human)
RGD
PMID:22766726
RGD:11041723
NCBI chr 9:14,740,182...14,778,171
Ensembl chr 9:14,740,182...14,778,171
G
Xrcc1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:SNP: :p.R194W
RGD
PMID:18199464
RGD:2293824
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Actl7a
actin-like 7a
ISO
RGD
PMID:29058301
RGD:13831338
NCBI chr 5:71,447,447...71,450,440
Ensembl chr 5:71,447,071...71,450,908
G
Birc5
baculoviral IAP repeat-containing 5
disease_progression
ISO
mRNA:increased expression:urinary bladder (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Birc7
baculoviral IAP repeat-containing 7
disease_progression
ISO
mRNA:increased expression:urinary bladder (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 3:168,047,824...168,052,606
Ensembl chr 3:168,047,824...168,052,606
G
Fgfr3
fibroblast growth factor receptor 3
severity
ISO
protein:increased expression:urothelial cells (human)
RGD
PMID:28507621
RGD:38500205
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
G
Kdm6a
lysine demethylase 6A
susceptibility
ISO
associated with upper tract urothelial carcinoma; DNA:mutations:multiple: (human)
RGD
PMID:30352907
RGD:150429735
NCBI chr X:4,337,466...4,477,100
Ensembl chr X:4,337,750...4,477,062
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all